On this basis, the present study investigated the clinical significance of PIK3CA and SOX2 gene amplification in early stages of laryngeal tumorigenesis by evaluating their predictive value for cancer risk assessment in 62 patients with laryngeal precancerous lesions. The gene discussed is PIK3CA; the disease is cancer.